Alaunos Therapeutics Investor Relations Material
Latest events
Q1 2023
Alaunos Therapeutics
Q2 2025
14 Aug, 2025
Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alaunos Therapeutics Inc
Access all reports
Alaunos Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative cell therapies for cancer treatment. The company specializes in T-cell receptor (TCR) therapies, leveraging its proprietary Sleeping Beauty non-viral gene transfer platform to engineer T-cells that target solid tumors with specific genetic mutations. Alaunos’s pipeline targets a range of cancers, including lung, ovarian, and pancreatic cancers. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
TCRT
Country
🇺🇸 United States